Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
In this week’s Nature Medicine, researchers report a groundbreaking phase 1/2 trial where a genetically engineered autologous stem cell therapy—designed to deliver interferon-α directly to glioblastoma tumors—showed stable engraftment and ... Read More
Continuous Coverage
The neon-soaked allure of the Las Vegas Strip has long been a cultural touchstone, a desert mirage of…
Thomson Reuters is rolling out a 1040 tax automation engine this week, blending generative AI with legacy tax…
A new experimental cancer treatment nearly doubled survival rates in a recent trial, offering hope for patients with…
Freddy Quinn, the Austrian singer and actor who defined the post-war German cultural landscape, remains an enduring icon…
Alabama mother mourns loss of two children during family swim, sparking national safety debates. The tragedy, occurring near…
NASA’s Nancy Grace Roman Space Telescope, set to revolutionize exoplanet discovery, could unveil 100,000 hidden worlds by 2031,…
Global Affairs
A cyclist was critically injured in a collision with a tractor on the E6 highway near Halden, Norway,…
Markets And Money
DNB Markets and Carnegie have tripled their valuation models for a specific, high-growth technology entity, yet both institutions…
Digital Culture
Leaked production footage from early June 2026 confirms Apple is finalizing the “iPhone Ultra,” a high-end foldable device…
Science And Wellbeing
Johnson & Johnson’s breakthrough in multiple myeloma therapy, announced this week, offers new hope for patients with limited…
Screen And Sound
As South Africa prepares for the annual Youth Month commemorations this June, a high-profile actress is leveraging her…
Fixtures And Form
Former England manager and Newcastle United legend Kevin Keegan, 75, has revealed he is battling stage four cancer…
